• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华支睾吸虫通过E2F1-CD24转录轴驱动肝癌发生:机制及治疗意义

Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications.

作者信息

Lu Wen-Min, Yan Jin, Liu Zhao-Ji, Wu Yong, Cui Qian-Ru, Feng Ji, Chen Yu, Zhu Guang-Zhi, Peng Tao, Zhou Jing, Lu Guo-Dong

机构信息

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.

Department of Physiology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China.

出版信息

Parasit Vectors. 2025 Aug 19;18(1):353. doi: 10.1186/s13071-025-06979-6.

DOI:10.1186/s13071-025-06979-6
PMID:40830893
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) remains a global health burden, with disproportionately high mortality in China's Guangxi region, where endemic Clonorchis sinensis (C. sinensis) infection coincides with elevated HCC incidence. Preliminary single-cell sequencing revealed marked overexpression of cluster of differentiation 24 (CD24) in HCC tissues, suggesting its potential pathological role. This study aims to elucidate the oncogenic mechanisms of C. sinensis excretory-secretory products (CsESPs) and their link to CD24-mediated HCC progression.

METHODS

We employed an integrated clinical and experimental approach. First, clinical cohort analysis assessed CD24 expression in C. sinensis-associated HCC cases. Multiplatform bioinformatics validation (GEPIA/UALCAN/TIMER) evaluated CD24's prognostic significance and immune microenvironment modulation. Functional studies (quantitative polymerase chain reaction (qPCR), Western blotting, CCK-8 assays, flow cytometry) examined CsESPs' effects on CD24 expression, cell proliferation, and apoptosis. Mechanistic investigations (chromatin immunoprecipitation, dual-luciferase reporter assays) identified E2F1-mediated transcriptional activation of CD24. siRNA-mediated CD24 knockdown validated its role in CsESPs-driven oncogenesis. Additionally, the expression of immune checkpoint (CTLA-4, LAG-3) was assessed in the co-cultures of peripheral blood mononuclear cells (PBMCs)-HCC cells.

RESULTS

Clinical cohort analysis confirmed significant CD24 upregulation in HCC, particularly in C. sinensis-infected cases. Bioinformatic analyses linked high CD24 expression to poor prognosis and immune microenvironment alterations. Functional assays demonstrated that CsESPs enhance CD24 expression, promoting proliferation and inhibiting apoptosis. Mechanistically, E2F1 directly binds to CD24 promoter, driving its transcription upon CsESPs exposure. CD24 silencing reversed CsESPs-induced oncogenic effects. Furthermore, CsESPs upregulated immune checkpoints (CTLA-4, LAG-3) in the co-cultures of PBMC-HCC cells, an effect reversed by CD24 knockdown.

CONCLUSIONS

Our findings establish a novel parasitic carcinogenesis paradigm wherein C. sinensis promotes HCC development through E2F1-mediated transcriptional activation of CD24, simultaneously identifying prognostic biomarkers and therapeutic targets while suggesting combinatory immunotherapy strategies for parasite-associated HCC.

摘要

背景

肝细胞癌(HCC)仍然是一个全球性的健康负担,在中国广西地区死亡率极高,该地区华支睾吸虫(C. sinensis)的地方性感染与HCC发病率升高同时存在。初步的单细胞测序显示HCC组织中分化簇24(CD24)明显过表达,提示其潜在的病理作用。本研究旨在阐明华支睾吸虫排泄分泌产物(CsESPs)的致癌机制及其与CD24介导的HCC进展的联系。

方法

我们采用了临床与实验相结合的方法。首先,临床队列分析评估了华支睾吸虫相关HCC病例中CD24的表达。多平台生物信息学验证(GEPIA/UALCAN/TIMER)评估了CD24的预后意义和免疫微环境调节。功能研究(定量聚合酶链反应(qPCR)、蛋白质免疫印迹法、CCK-8检测、流式细胞术)检测了CsESPs对CD24表达、细胞增殖和凋亡的影响。机制研究(染色质免疫沉淀、双荧光素酶报告基因检测)确定了E2F1介导的CD24转录激活。siRNA介导的CD24敲低验证了其在CsESPs驱动的肿瘤发生中的作用。此外,在人外周血单个核细胞(PBMC)-HCC细胞共培养中评估了免疫检查点(CTLA-4、LAG-3)的表达。

结果

临床队列分析证实HCC中CD24显著上调,尤其是在华支睾吸虫感染的病例中。生物信息学分析将高CD24表达与不良预后和免疫微环境改变联系起来。功能试验表明,CsESPs增强CD24表达,促进增殖并抑制凋亡。机制上,E2F1直接结合到CD24启动子上,在暴露于CsESPs时驱动其转录。CD24沉默逆转了CsESPs诱导的致癌作用。此外,CsESPs上调了PBMC-HCC细胞共培养中的免疫检查点(CTLA-4、LAG-3),CD24敲低可逆转这一作用。

结论

我们的研究结果建立了一种新的寄生虫致癌模式,即华支睾吸虫通过E2F1介导的CD24转录激活促进HCC发展,同时确定了预后生物标志物和治疗靶点,并提出了针对寄生虫相关HCC的联合免疫治疗策略。

相似文献

1
Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications.华支睾吸虫通过E2F1-CD24转录轴驱动肝癌发生:机制及治疗意义
Parasit Vectors. 2025 Aug 19;18(1):353. doi: 10.1186/s13071-025-06979-6.
2
Clonorchis sinensis infection remodels chromatin accessibility in hepatocellular carcinoma.华支睾吸虫感染重塑肝细胞癌中的染色质可及性。
Parasit Vectors. 2025 Jul 10;18(1):276. doi: 10.1186/s13071-025-06909-6.
3
Non-canonical activation of MAPK signaling by the lncRNA ASH1L-AS1-encoded microprotein APPLE through inhibition of PP1/PP2A-mediated ERK1/2 dephosphorylation in hepatocellular carcinoma.在肝细胞癌中,长链非编码RNA ASH1L-AS1编码的微小蛋白APPLE通过抑制PP1/PP2A介导的ERK1/2去磷酸化对MAPK信号通路进行非经典激活。
J Exp Clin Cancer Res. 2025 Jul 11;44(1):200. doi: 10.1186/s13046-025-03465-w.
4
Multi-omics analysis of lactate metabolism gene regulation in Clonorchis sinensis-associated hepatocellular carcinoma.华支睾吸虫相关肝细胞癌中乳酸代谢基因调控的多组学分析
Parasit Vectors. 2025 Jul 27;18(1):301. doi: 10.1186/s13071-025-06947-0.
5
CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma.CD24招募肿瘤相关中性粒细胞以促进肝细胞癌进展。
J Immunother Cancer. 2025 Aug 21;13(8):e012118. doi: 10.1136/jitc-2025-012118.
6
The microRNA landscape and regulatory network in Clonorchis sinensis-infected hepatocellular carcinoma: implications for tumor progression.华支睾吸虫感染的肝细胞癌中的微小RNA景观和调控网络:对肿瘤进展的影响
Parasit Vectors. 2025 Feb 21;18(1):68. doi: 10.1186/s13071-025-06689-z.
7
infected hepatocellular carcinoma exhibits distinct tumor microenvironment and molecular features.感染性肝细胞癌表现出独特的肿瘤微环境和分子特征。
Front Immunol. 2025 Mar 17;16:1526699. doi: 10.3389/fimmu.2025.1526699. eCollection 2025.
8
Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.白藜芦醇通过下调 AKR1C3 抑制肝癌进展:以 HSA 纳米材料为载体靶向 HCC 以增强治疗效果。
Apoptosis. 2024 Oct;29(9-10):1429-1453. doi: 10.1007/s10495-024-01995-w. Epub 2024 Jul 18.
9
Disulfidptosis-related genes RPN1 inhibits the progression of hepatocellular carcinoma by regulating cell cycle, may be a new therapeutic targets.二硫键连接的细胞焦亡相关基因RPN1通过调控细胞周期抑制肝细胞癌进展,可能是新的治疗靶点。
Inflamm Res. 2025 Jul 22;74(1):105. doi: 10.1007/s00011-025-02070-z.
10
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.SNRPB/CCNB1轴通过增强脂质代谢重编程促进肝细胞癌进展和顺铂耐药。
J Exp Clin Cancer Res. 2025 Jul 18;44(1):211. doi: 10.1186/s13046-025-03463-y.

本文引用的文献

1
Reduced exosomal miR-215-5p activates the NEAT1/MAPK1/p-CRMP2 pathway and contributes to social dysfunction in a VPA-induced autism model.外泌体 miR-215-5p 水平降低会激活 NEAT1/MAPK1/p-CRMP2 信号通路,并导致丙戊酸诱导的自闭症模型出现社交功能障碍。
Neuropharmacology. 2025 Nov 1;278:110539. doi: 10.1016/j.neuropharm.2025.110539. Epub 2025 Jun 2.
2
Artesunate demonstrates neuroprotective effect through activation of lysosomal function and inhibition of cGAS-STING pathway.青蒿琥酯通过激活溶酶体功能和抑制cGAS-STING通路发挥神经保护作用。
Neuropharmacology. 2025 Jul 1;272:110426. doi: 10.1016/j.neuropharm.2025.110426. Epub 2025 Mar 19.
3
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA.
ADARp110通过稳定CD24信使核糖核酸促进肝细胞癌进展。
Proc Natl Acad Sci U S A. 2025 Jan 21;122(3):e2409724122. doi: 10.1073/pnas.2409724122. Epub 2025 Jan 14.
4
Clonorchis sinensis infection contributes to hepatocellular carcinoma progression via enhancing angiogenesis.华支睾吸虫感染通过促进血管生成促进肝细胞癌的进展。
PLoS Negl Trop Dis. 2024 Nov 11;18(11):e0012638. doi: 10.1371/journal.pntd.0012638. eCollection 2024 Nov.
5
CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers.CD24影响多种癌症中肿瘤浸润细胞的免疫抑制作用和肿瘤抗性。
Discov Oncol. 2024 Sep 2;15(1):399. doi: 10.1007/s12672-024-01284-7.
6
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
Unraveling the role of CD24 in Hepatocellular carcinoma: Involvement of inactivated Hippo signaling and SOX4-mediated regulation.解析 CD24 在肝细胞癌中的作用:失活 Hippo 信号和 SOX4 介导的调控涉及其中。
Biochim Biophys Acta Mol Basis Dis. 2024 Apr;1870(4):167117. doi: 10.1016/j.bbadis.2024.167117. Epub 2024 Mar 8.
9
Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis.华支睾吸虫感染增强肝癌干细胞特性,预测不良预后。
PLoS Negl Trop Dis. 2024 Jan 29;18(1):e0011906. doi: 10.1371/journal.pntd.0011906. eCollection 2024 Jan.
10
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data.中国 2005-20 年的癌症负担的国家和省级趋势:基于国家死亡率监测数据的分析。
Lancet Public Health. 2023 Dec;8(12):e943-e955. doi: 10.1016/S2468-2667(23)00211-6.